Abstract
The present study compared the efficacy of amitraz, doramectin, imidacloprid + moxidectin, test product (Green clean), and its combinations in the clinical management of canine generalized demodicosis. A total of 48 positive cases of generalized demodicosis were selected for the therapeutic trial. The affected dogs were divided into 6 groups, viz., A, B, C, D, E, and F; each group comprised 8 dogs. Six healthy dogs negative for demodectic mites were also used as control (group G) for comparison. The response to treatment was assessed by conducting a clinical examination and parasitological examination of cases at weekly intervals included in the therapeutic trial till clinical recovery (4-7 weeks) or treatment failure. Treatment regimens comprising of a combination of systemic miticidal drugs (doramectin @ 600 µg/kg b.wt. s/c weekly) and a topical miticidal compound (amitraz @ 500 ppm spray weekly or test product 5% spray twice daily) with supportive therapy were more efficacious in resolving the lesions and eliminating the mites than the treatment regimens having single drug (doramectin/amitraz/test product). The combination therapy, along with supportive therapy with benzyl peroxide shampoo, produced appreciable therapeutic results. There was no significant difference between different treatment groups, except Group D (test product), which took a long time for clinical cure.
The full text of this article is available as a PDF.
Download PDF- Cerundolo, R. (2017). Diagnostic and therapeutic approach to common ectoparasitoses in small animal practice. In Practice, 35(1), 18-23.
- Chansiripornchi, P., & Chansiripornchi, N. (2017). Treatment of recurrent demodicosis in dogs using doramectin injection. Indian Veterinary Journal, 94(9), 58-89.
- Dimri, U., Singh, S.K., Sharma, M.C., & Kumar, N. (2009). Efficacy of doramectin against canine demodicosis. Indian Veterinary Journal, 86(11), 1127-1128.
- Fourie, J.J., Delport, P.C., Fourie, L.J., Heine, J., Horak, I.G., & Krieger, K.J. (2009). Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (Advocate®) against generalised demodicosis in dogs. Parasitology Research, 105(1), 115-124.
- Fourie, J.J., Liebenberg, J.E., Horak, I.G., Taenzler, J., Heckeroth, A.R., & Frénais, R. (2015). Efficacy of orally administered fluralaner (Bravecto TM) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
- Parasites & Vectors, 8(1), 187.
- Hugnet, C., Bruchon-Hugnet, C., Royer, H., & Bourdoiseau, G. (2001). Efficacy of 1.25% amitraz solution in the treatment of generalized demodicosis (eight cases) and sarcoptic mange (five cases) in dogs. Veterinary Dermatology, 12(2), 89-92.
- Hutt, J.H., Prior, I.C., & Shipstone, M.A. (2015). Treatment of canine generalized demodicosis using weekly injections of doramectin: 232 cases in the USA (2002–2012). Veterinary Dermatology, 26(5), 345-e73.
- Kumar, D., Arya, V., Kaur, R., Bhat, Z.A., Gupta, V.K., & Kumar, V. (2012). A review of immunomodulators in the Indian traditional
- health care system. Journal of Microbiology, Immunology and Infection, 45(3),165-184.
- Medleau, L., & Willemse, T. (1995). Efficacy of daily amitraz on generalised demodicosis in dogs. Journal of Small Animal Practice, 36(1), 3-6.
- Mueller, R.S. (2012). An update on the therapy of canine demodicosis. Compendium Continuing Education for Veterinarian, 34(4), E1-4. Nauriyal, D.S. (2015). A project report on "Evaluation of efficacy of nanotechnology based formulation against infections/
- infestations of canine skin" submitted to Anand Agricultural University, Anand, Gujarat, India, p. 1-31.
- Patel, J.K. (2012). Etio-diagnosis and therapeutic studies on canine demodicosis with special references to lymphocyte blastogenesis and cytokine expression in demodectic dogs. M.V.Sc thesis, Anand Agricultural University, Anand, Gujarat, India.
- Paterson, T.E., Halliwell, R.E., Fields, P.J., Louw, M.L., Ball, G., Louw, J., & Pinckney, R. (2014). Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+ 10% imidacloprid spot-on and oral ivermectin: Parasiticidal effects and long-term treatment outcomes. Veterinary Parasitology, 205(3-4), 687-696.
- Paterson, T.E., Halliwell, R.E., Fields, P.J., Louw, M.L., Louw, J.P., Ball, G.S., ... and McKibben, J.S. (2009). Treatment of canine‐
- generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of Advocate®(Bayer Animal Health) with ivermectin. Veterinary Dermatology, 20(5‐6): 447-455.
- Perego, R., Spada, E., Foppa, C., & Proverbio, D. (2019). Critically appraised topic for the most effective and safe treatment for canine generalised demodicosis. BMC Veterinary Research, 15(1), 17.
- Ravera, I., Ferreira, D., Gallego, L.S., Bardagí, M., & Ferrer, L. (2015). Serum detection of IgG antibodies against Demodex canis by western blot in healthy dogs and dogs with juvenile generalized demodicosis. Research in Veterinary Science, 101, 161-164.
- Shrestha, D., Thapa, B., Rawal, G., Dhakal, S., & Sharma, B. (2015). Prevalence of demodectic mange in canines of Kathmandu Valley having skin disorder and its associated risk factors. International Journal of Applied Sciences and Biotechnology, 3(3), 459-463.
- Singh, H., Haque, M., Singh, N.K., & Rath, S.S. (2011). Prevalence of canine parasitic infections in and around Ludhiana, Punjab. Journal of Veterinary Parasitology, 25(2), 179-180.
- Snedecor, G.W., & Cochran, W.G. (1994). Statistical Methods, 7th edn, Oxford and JBH Publishing, New York, USA.
Looking up citing articles…

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.